Enanta Pharmaceuticals, Inc. (ENTA)
13.18
-0.34
(-2.55%)
USD |
NASDAQ |
May 27, 16:00
13.00
-0.18
(-1.40%)
After-Hours: 17:46
Enanta Pharmaceuticals Cash from Investing (Quarterly) : 11.94M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cyclerion Therapeutics, Inc. | -0.066M |
| Keros Therapeutics, Inc. | -0.073M |
| ACADIA Pharmaceuticals, Inc. | 66.28M |
| Alnylam Pharmaceuticals, Inc. | -25.54M |
| Amgen, Inc. | -716.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.156M |
| Cash from Financing (Quarterly) | -7.295M |
| Free Cash Flow | -9.609M |
| Free Cash Flow Per Share (Quarterly) | -0.2469 |
| Free Cash Flow to Equity (Quarterly) | -0.605M |
| Free Cash Flow to Firm (Quarterly) | -3.853M |
| Free Cash Flow Yield | -2.90% |